Clinical Trial to Study a Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence Overactive Bladder (OAB)

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

March 31, 2011

Conditions
Overactive Bladder
Interventions
DEVICE

Non-invasive neurostimulation device

Active electrode patches are worn for 4 weeks, one per week, during the treatment phase of the study. The patch is placed by the investigator.

DEVICE

Non-invasive neurostimulation device

Active electrode patches are worn for 4 weeks, one per week, during the treatment phase of the study. The patch is placed by the subject.

Trial Locations (11)

20037

Medical Faculty Associates, The George Washington University, Washington D.C.

27403

Alliance Urology Specialists, P.A., Greensboro

28207

McKay Urology, Charlotte

29425

Medical University of South Carolina, Charleston

37232

Vanderbilt University Medical Center, Nashville

48073

William Beaumont Hospital - Department of Urology, Royal Oak

53226

Wheaton Franciscan Medical Group, Milwaukee Urogynecology, Wauwatosa

08648

AdvanceMed Research, Lawrenceville

08054

Delaware Valley Urology, LLC, Mount Laurel

182 88

Danderyd University Hospital, Stockholm

S016 5YA

Princess Anne Hospital, Southampton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novella Clinical

OTHER

collaborator

Data & Inference, Inc.

INDUSTRY

lead

Ethicon Endo-Surgery

INDUSTRY

NCT01125722 - Clinical Trial to Study a Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence Overactive Bladder (OAB) | Biotech Hunter | Biotech Hunter